Optimizing anti‐T‐lymphocyte globulin dosing to improve long‐term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimizing anti‐T‐lymphocyte globulin dosing to improve long‐term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies

Published:2019-11-16 Issue:3 Volume:20 Page:677-688
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Turki Amin T.¹²^ORCID,Klisanin Vesna¹,Bayraktar Evren¹³,Kordelas Lambros¹,Trenschel Rudolf¹,Ottinger Hellmut¹,Steckel Nina K.¹,Tsachakis‐Mück Nikolaos¹,Leserer Saskia¹,Ditschkowski Markus¹,Liebregts Tobias¹,Koldehoff Michael¹,Fleischhauer Katharina²^ORCID,Beelen Dietrich W.¹^ORCID

Affiliation:

1. Department of Bone Marrow Transplantation West‐German Cancer Center University Hospital Essen Essen Germany

2. Institute for Experimental Cellular Therapy University Hospital Essen Essen Germany

3. Chair of Applied Mathematics and Numerics TU Dortmund University Dortmund Germany

Funder

Universität Duisburg-Essen

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15642

Reference35 articles.

1. Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

2. Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

3. SIX WEEKS OF CONTINUOUS INTRAVENOUS CYCLOSPORINE AND SHORT-COURSE METHOTREXATE AS PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION

4. Induction of Fas (Apo-1, CD95)-Mediated Apoptosis of Activated Lymphocytes by Polyclonal Antithymocyte Globulins

5. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Early Cytomegalovirus Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients With Myelodysplastic Syndrome: A Nationwide Retrospective Study From Adult Myelodysplastic Syndrome Working Group of the JSTCT;Transplantation and Cellular Therapy;2024-07

2. Early T-cell reconstitution predicts risk of EBV reactivation after allogeneic hematopoietic stem cell transplantation;Clinical and Experimental Medicine;2024-01-27

3. The Value of Prognostic Nutritional Index Combined with Urea-Creatinine Ratio in Assessing the Prognosis of Transplantation in Patients Undergoing Haploidentical Stem Cell Transplantation;Advances in Clinical Medicine;2024

4. Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study);2023-11-30

5. Impact of the Recipient’s Pre-Treatment Blood Lymphocyte Count on Intended and Unintended Effects of Anti-T-Lymphocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation;Cells;2023-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3